Compositions including quinonoid derivatives of cannabinoids for therapeutic use
US8497299B2 · kind B2 · utility
8Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2005 |
| Grant date | Jul 30, 2013 |
| Priority date | — |
| Expiry date | Dec 26, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D311/80
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to cannabinoic quinone compounds, and especially to their medical use. In particular five cannabinoic quinones, designated HU-331, HU-336, HU-345, HU-395 and HU-396, are described as active agents in pharmaceutical compositions. These compounds and compositions thereof are intended for the treatment of inflammatory, infectious, auto-immune and particularly hyperproliferative disorders. Thus, the compounds of the invention may be used as anti-tumor agents, or for the treatment of cancer. Furthermore, three of these compounds, HU-345, HU-395 and HU-396, are novel cannabinoic quinones.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.